Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation

被引:37
作者
Buchbinder, S
Elmaagacli, AH
Schaefer, UW
Roggendorf, M
机构
[1] Univ Hosp Essen, Inst Virol, Essen, Germany
[2] Univ Hosp Essen, Dept Bone Marrow Transplantat, Essen, Germany
[3] Univ Leipzig, Inst Virol, D-04103 Leipzig, Germany
关键词
bronchoalveolar lavage; interstitial pneumonia; human cytomegalovirus; human herpesvirus 6; acute graft-versus-host disease; engraftment;
D O I
10.1038/sj.bmt.1702569
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Two hundred and ten bronchoalveolar lavage (BAL) samples were obtained from 50 patients 10 days before and on defined days after allogeneic bone marrow transplantation (BMT). The samples were examined for human cytomegalovirus (HCMV) and human herpesvirus-6 (HHV-6) by polymerase chain reaction (PCR), Fifteen patients (30%) had a positive result for HCMV in at least one sample and 25 (50%) were positive for HHV-6 in at least one sample, Five patients developed HCMV-associated interstitial pneumonia (HCMV-IP) within 100 days after allogeneic BMT. Four of these patients were positive for both HCMV and HHV-6. Conspicuous HHV-6 positivity was detected in BAL samples obtained because of respiratory symptoms. No association was found between detection of HHV-6 and acute graft-versus-host disease. Engraftment failure or a delay in engraftment was observed in none of the 50 patients. The data from this study indicate that HHV-6 is a pathogen in HCMV-associated, as well as in non-HCMV-associated infectious lung disease after BMT.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 38 条
[1]   GENOMIC POLYMORPHISM, GROWTH-PROPERTIES, AND IMMUNOLOGICAL VARIATIONS IN HUMAN HERPESVIRUS-6 ISOLATES [J].
ABLASHI, DV ;
BALACHANDRAN, N ;
JOSEPHS, SF ;
HUNG, CL ;
KRUEGER, GRF ;
KRAMARSKY, B ;
SALAHUDDIN, SZ ;
GALLO, RC .
VIROLOGY, 1991, 184 (02) :545-552
[2]   SEVERE INFECTIOUS-MONONUCLEOSIS LIKE SYNDROME AND PRIMARY HUMAN HERPESVIRUS-6 INFECTION IN AN ADULT [J].
AKASHI, K ;
EIZURU, Y ;
SUMIYOSHI, Y ;
MINEMATSU, T ;
HARA, S ;
HARADA, M ;
KIKUCHI, M ;
NIHO, Y ;
MINAMISHIMA, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :168-171
[3]   6 WEEKS OF CONTINUOUS INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE METHOTREXATE AS PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
BEELEN, DW ;
QUABECK, K ;
KAISER, B ;
WIEFELSPUTZ, J ;
SCHEULEN, ME ;
GRAEVEN, U ;
GROSSEWILDE, H ;
SAYER, HG ;
SCHAEFER, UW .
TRANSPLANTATION, 1990, 50 (03) :421-427
[4]   Human herpesvirus 6: An emerging pathogen [J].
Campadelli-Fiume, G ;
Mirandola, P ;
Menotti, L .
EMERGING INFECTIOUS DISEASES, 1999, 5 (03) :353-366
[5]  
CARRIGAN DR, 1994, BLOOD, V84, P3307
[6]   INTERSTITIAL PNEUMONITIS ASSOCIATED WITH HUMAN HERPESVIRUS-6 INFECTION AFTER MARROW TRANSPLANTATION [J].
CARRIGAN, DR ;
DROBYSKI, WR ;
RUSSLER, SK ;
TAPPER, MA ;
KNOX, KK ;
ASH, RC .
LANCET, 1991, 338 (8760) :147-149
[7]   PREVALENCE OF HUMAN HERPESVIRUS-6 VARIANT-A AND VARIANT-B INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS AS DETERMINED BY POLYMERASE CHAIN-REACTION AND SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE HYBRIDIZATION [J].
DROBYSKI, WR ;
EBERLE, M ;
MAJEWSKI, D ;
BAXTERLOWE, LA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (06) :1515-1520
[8]   FATAL ENCEPHALITIS DUE TO VARIANT-B HUMAN HERPESVIRUS-6 INFECTION IN A BONE MARROW-TRANSPLANT RECIPIENT [J].
DROBYSKI, WR ;
KNOX, KK ;
MAJEWSKI, D ;
CARRIGAN, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (19) :1356-1360
[9]   ACTIVATION OF THE EPSTEIN-BARR-VIRUS REPLICATIVE CYCLE BY HUMAN HERPESVIRUS-6 [J].
FLAMAND, L ;
STEFANESCU, I ;
ABLASHI, DV ;
MENEZES, J .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6768-6777
[10]  
FRENKEL N, 1994, BONE MARROW TRANSPL, V14, P839